These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34635393)

  • 1. RORγt protein modifications and IL-17-mediated inflammation.
    Kumar R; Theiss AL; Venuprasad K
    Trends Immunol; 2021 Nov; 42(11):1037-1050. PubMed ID: 34635393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.
    Xue X; Soroosh P; De Leon-Tabaldo A; Luna-Roman R; Sablad M; Rozenkrants N; Yu J; Castro G; Banie H; Fung-Leung WP; Santamaria-Babi L; Schlueter T; Albers M; Leonard K; Budelsky AL; Fourie AM
    Sci Rep; 2016 Dec; 6():37977. PubMed ID: 27905482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases.
    Rutz S; Eidenschenk C; Kiefer JR; Ouyang W
    Cytokine Growth Factor Rev; 2016 Aug; 30():1-17. PubMed ID: 27481185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORγt.
    Yang J; Xu P; Han L; Guo Z; Wang X; Chen Z; Nie J; Yin S; Piccioni M; Tsun A; Lv L; Ge S; Li B
    J Immunol; 2015 May; 194(9):4094-7. PubMed ID: 25821221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RORγt expression in T
    Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
    Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression.
    Wang X; Yang J; Han L; Zhao K; Wu Q; Bao L; Li Z; Lv L; Li B
    J Biol Chem; 2015 Nov; 290(48):29086-94. PubMed ID: 26453305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pak2-mediated phosphorylation promotes RORγt ubiquitination and inhibits colonic inflammation.
    Kathania M; Kumar R; Lenou ET; Basrur V; Theiss AL; Chernoff J; Venuprasad K
    Cell Rep; 2022 Sep; 40(11):111345. PubMed ID: 36103814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesis.
    Shapiro M; Nandi B; Pai C; Samur MK; Pelluru D; Fulciniti M; Prabhala RH; Munshi NC; Gold JS
    Cancer Immunol Immunother; 2016 Jan; 65(1):13-24. PubMed ID: 26559812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RORγt phosphorylation protects against T cell-mediated inflammation.
    Ma S; Patel SA; Abe Y; Chen N; Patel PR; Cho BS; Abbasi N; Zeng S; Schnabl B; Chang JT; Huang WJM
    Cell Rep; 2022 Mar; 38(11):110520. PubMed ID: 35294872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
    Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
    Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses.
    Ecoeur F; Weiss J; Kaupmann K; Hintermann S; Orain D; Guntermann C
    Front Immunol; 2019; 10():577. PubMed ID: 30972071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of RORγt in developing Th17 cells is regulated by E-proteins.
    Zhang F; Fuss IJ; Yang Z; Strober W
    Mucosal Immunol; 2014 May; 7(3):521-32. PubMed ID: 24064669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation of RORγt regulates T
    He Z; Zhang J; Huang Z; Du Q; Li N; Zhang Q; Chen Y; Sun Z
    Nat Commun; 2018 Nov; 9(1):4870. PubMed ID: 30451821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells.
    Mortier C; Gracey E; Coudenys J; Manuello T; Decruy T; Maelegheer M; Stappers F; Gilis E; Gaublomme D; Van Hoorebeke L; Van Welden S; Ambler C; Hegen M; Symanowicz P; Steyn S; Berstein G; Elewaut D; Venken K
    Rheumatology (Oxford); 2023 Sep; 62(9):3169-3178. PubMed ID: 36661300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.
    Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C
    PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
    Qiu J; Zhou L
    Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.